BOLD Q1 2024 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$17M

Net Income

-$15M

EPS (Diluted)

$-0.69

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$117M

Total Liabilities

$258M

Stockholders' Equity

-$141M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$17M	-$12M	-39.7%
Net Income	-$15M	-$12M	-31.7%